Cite
HARVARD Citation
Sakata, Y. et al. (2019). Comparisons between tumor burden and other prognostic factors that influence survival of patients with non‐small cell lung cancer treated with immune checkpoint inhibitors. Thoracic cancer. 10 (12), pp. 2259-2266. [Online].